Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4100419
Max Phase: Preclinical
Molecular Formula: C68H92Na4O11
Molecular Weight: 1089.50
Molecule Type: Small molecule
Associated Items:
ID: ALA4100419
Max Phase: Preclinical
Molecular Formula: C68H92Na4O11
Molecular Weight: 1089.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCOc1c2cc(C(=O)[O-])cc1Cc1cc(C(=O)[O-])cc(c1OCCCCCCCCCCCC)Cc1cc(C(=O)[O-])cc(c1OCCCCCCCCCCCC)Cc1cc(cc(C(=O)[O-])c1)C2.[Na+].[Na+].[Na+].[Na+]
Standard InChI: InChI=1S/C68H96O11.4Na/c1-4-7-10-13-16-19-22-25-28-31-34-77-62-52-38-50-37-51(41-58(40-50)65(69)70)39-53-45-60(67(73)74)47-55(63(53)78-35-32-29-26-23-20-17-14-11-8-5-2)43-57-49-61(68(75)76)48-56(42-54(62)46-59(44-52)66(71)72)64(57)79-36-33-30-27-24-21-18-15-12-9-6-3;;;;/h37,40-41,44-49H,4-36,38-39,42-43H2,1-3H3,(H,69,70)(H,71,72)(H,73,74)(H,75,76);;;;/q;4*+1/p-4
Standard InChI Key: LWRLYZDEDBYAMG-UHFFFAOYSA-J
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1089.50 | Molecular Weight (Monoisotopic): 1088.6953 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Sestito SE, Facchini FA, Morbioli I, Billod JM, Martin-Santamaria S, Casnati A, Sansone F, Peri F.. (2017) Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling., 60 (12): [PMID:28471658] [10.1021/acs.jmedchem.7b00095] |
Source(1):